ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natarajan, G.
Right arrow Articles by Aranda, J. V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Natarajan, G.
Right arrow Articles by Aranda, J. V
Annals of Clinical & Laboratory Science 37:170-176 (2007)
© 2007 Association of Clinical Scientists

Nitric Oxide and Prostaglandin Response to Group B Streptococcal Infection in the Lung

Girija Natarajan, Maria Glibetic, Vania Raykova, John P Ofenstein, Ronald L Thomas and Jacob V Aranda
Division of Clinical Pharmacology, Children’s Hospital of Michigan, Detroit, Michigan

Address correspondence to Girija Natarajan, M.D., Division of Neonatology, Children’s Hospital of Michigan, 3901 Beaubien Blvd, Detroit, MI 48201, USA; tel 313 993 2929; fax 313 745 5862; e-mail natarajan_girija{at}yahoo.com. Maria Glibetic, Ph.D., is now at the Department for Nutrition and Metabolism, Institute for Medical Research, Beograd, Serbia & Montenegro.

Group B streptococcus (GBS) causes a complex inflammatory process that involves prostaglandins (PG) and nitric oxide (NO). The goal of this study was to examine the inflammatory response to GBS in the lung and the co-regulation of the PG and NO pathways, if any, both in vitro and in vivo. Sprague Dawley rats were treated with various combinations of GBS, aminoguanidine (AG), a selective inducible nitric oxide synthase (iNOS) inhibitor, and L-arginine (LA), a NO donor. The mRNA expression of the COX 2 gene was studied by reverse transcriptase polymerase chain reaction (RTPCR) in rat lung tissue. The studies were confirmed in vitro using human lung epithelial (A549) cells treated with GBS, AG, and LA (in combinations similar to the rats) for 3 and 24 hr, after which PG E2 levels in the media were measured by enzyme linked immunosorbent assay (ELISA). COX 2 mRNA in rat lung tissue was significantly induced by GBS (p = 0.04), an effect that was suppressed by AG (p = 0.02). In the A549 cell line, PG E2 levels increased with GBS treatment at 3 and 24 hr (p <0.001). When AG was added, PG E2 levels were suppressed (p = 0.03) after 24 hr; LA partly reversed the suppression of PG E2 levels (p = 0.039). These data indicate that GBS infection causes significant COX 2 induction and PG E2 synthesis in lung tissue, regulated at least partly by the NO pathway. The interaction between the 2 pathways may play a pathogenic role in GBS lung infections and could be a potential target for pharmacological manipulation.

Keywords: Group B streptococcus, nitric oxide, prostaglandins, aminoguanidine, COX gene expression







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association of Clinical Scientists.